GL9 — Glanbia Balance Sheet
0.000.00%
- €4.16bn
- €4.71bn
- $3.95bn
Annual balance sheet for Glanbia, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.
R2022 December 31st | R2022 January 1st | 2023 December 30th | 2025 January 4th | 2026 January 3rd | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 468 | 262 | 414 | 417 | 491 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 398 | 417 | 492 | 383 | 464 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,655 | 1,619 | 1,483 | 1,487 | 1,652 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 612 | 663 | 603 | 606 | 611 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,117 | 4,109 | 3,799 | 3,875 | 3,974 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,195 | 1,005 | 881 | 1,055 | 1,219 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,133 | 2,147 | 1,667 | 1,802 | 2,047 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 1,984 | 1,962 | 2,133 | 2,073 | 1,927 |
| Total Liabilities & Shareholders' Equity | 4,117 | 4,109 | 3,799 | 3,875 | 3,974 |
| Total Common Shares Outstanding |